Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature

Rationale: Spinal cord infarction (SCI) accounted for only 1% to 2% of all ischemic strokes and 5% to 8% of acute myelopathies. Magnetic resonance imaging (MRI) play a role in the exclusion of non-ischemic etiology, but the diagnostic accuracy of this procedure may be low in confirming the diagnosis, even when the vast marrow lesions are present. Indeed, changes in MRI T2 can develop from hours to days, thus accounting for the low sensitivity in the setting of hyperacute (ie, within 6 hours of onset of symptoms).

For this reason, SCI remains a clinical diagnosis. Although the diagnostic work-up wide, up to 20% to 40% of cases of SCI are classified as cryptogenic. Here, we describe a case of cryptogenic longitudinally extensive transverse myelopathy due to SCI, with negative MRI and diffusion-weighted imaging at 9 hours after the initial symptoms.

patient concerns: A 51 years old woman presented to our emergency department with severe acute abdominal pain, nausea, vomiting, sudden-onset bilateral leg weakness with diffuse sensory loss and paraesthesia in the trunk and legs.
Diagnosis: On neurological examination, she showed severe paraparesis and sensory level D6. A spinal cord 3T MRI with gadolinium performed at 9 hours after onset of symptoms does not detect changes in the spinal cord. Due to the persistence of a suggestive clinical picture of myelopathy acute, 3T MRI of the spine was repeated after 72 hours showed hyperintense “pencil-like” signals mainly involving the gray matter of T1 to T6 at T2 sequence, slightly hypointense on T1 and the diffusion limited.

Intervention: Patients were given a salicylic acid (100 mg / d), a low molecular weight heparin prophylaxis, and start neuromotor rehabilitation.
Results: Two months later, a follow-up neurological examination revealed severe spastic paraparesis, there is a clear sensory level and sphincter control was poor with bladder distension.

Lesson: Apart from a relatively low frequency in the general population, SCI should be suspected in any patient presenting with symptoms of acute and progressive myelopathic, even without the presence of vascular risk factors. Thus, the clinical presentation consistent with a potential vascular syndromes involving the spinal cord MRI override initially negative and should not delay the timely and proper management.

Cultivated tomato (Solanum lycopersicum L.) suffer severe bottlenecks during domestication of the strain: Implications of the chloroplast genome

In a variety of plants, genetic bottlenecks occur through domestication can limit plant resistance to biotic and abiotic stresses. In this study, we investigated the nucleotide diversity in tomato chloroplast genome by sequencing seven plastomes of cultivated accessions from the Campania region (southern Italy) and two wild species among the closest (Solanum pimpinellifolium) and most distantly related (S. neorickii) tomato species cultivated. comparative analysis between the chloroplast genome sequenced in this work and are available at GenBank allowed to evaluate the variability plastomes and defining phylogenetic relationships.

A dramatic reduction in genetic diversity detected in cultivated tomatoes, however, de novo mutations some, still distinguishable tomatoes cultivated from the nearest wild relative S. pimpinellifolium, which are detected and can potentially be used as a diagnostic marker. phylogenetic analysis confirms that S. pimpinellifolium is the closest ancestor of all cultivated tomatoes. Local accession all gathered together and strictly related to other cultivated tomato (S. lycopersicum group). Noteworthy, S. lycopersicum var. cerasiforme resulting in a mix of both cultivated and wild tomato genotypes for one of the two accessions analyzed teem with tomatoes cultivated, whereas others with S. pimpinellifolium.

 Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature

The whole exome Analysis of Congenital Muscular Dystrophy and congenital myopathy patients from India Unveils Wide Spectrum of Known and Novel Mutation

Background: Congenital muscular dystrophy (CMD) and the congenital myopathies (CM) is a clinically heterogeneous group of genetic and degenerative primary muscle disorder with onset at birth or during infancy. Due to the extensive heterogeneity, clinical examination and analysis of protein-based often fail to identify the genetic causes of this disease.

Methods: Whole exome sequencing (WES) conducted to identify genetic mutations and diagnose pathogens cohort of 36 hard-to-diagnose cases CM CMD and Indian origin, using a variant of the call and a rigorous filtration process variants. Furthermore, in silico modeling and molecular dynamics (MD) study conducted for a number of novels and missense variants.

Results: A total of 33 and 21 rare and damaging mutations identified in 28 genes were previously reported in CMD and CM based OMIM, ClinVar and Orphanet, respectively. We can accurately diagnose 54% of patients (n = 12/22) in the group of CMD and 35% of patients (n = 5/14) in the group CM. Furthermore, the study for the MD is located in LMNA mutations, lama2 and RYR1, indicating that the wild type of protein is more stable than their mutant counterparts, implying a potential mechanism of pathogenesis.

NATtrol Zika Virus (PRVABC59), External Run Control, Low (6 x 1.0 mL)

NATZIKV(PRV)-ERCL 6 x 1.0 mL
EUR 350

NATtrol Staphylococcus aureus (MSSA); -mecA, External Run Control, Low (6X1mL)

NATSAU(MSSA)-ERCL 6X1mL
EUR 360

NATtrol HIV Type 1 Strain: IIIB External Run Control, Low (6 X 1 mL)

NATHIV1-ERCL 6 X 1 mL
EUR 360

NATtrol Clostridium difficile NAP1, External Run Control, Low (6 X 1 mL)

NATCDI(NAP1)-ERCL 6 X 1 mL
EUR 438

NATtrol Mycoplasma pneumoniae M129, External Run Control, Low (6 X 1 mL)

NATMPN(M129)-ERCL 6 X 1 mL
EUR 360

NATtrol Neisseria gonorrhoeae Z017, External Run Control, Low (6 X 1 mL)

NATNG-ERCL 6 X 1 mL
EUR 360

NATtrol Staphylococcus aureus (MRSA) External Run Control, Low (6 X 1 mL)

NATSAU(MRSA)-ERCL 6 X 1 mL
EUR 360

NATtrol Cytomegalovirus (CMV) Strain: AD-169 External Run Control, Low (6X1 mL)

NATCMV-ERCL 6X1 mL
EUR 360

NATtrol Escherichia coli 0157:H7;EDL933, External Run Control, Low (6 X 1 mL)

NATECO(933)-ERCL 6 X 1 mL
EUR 360

NATtrol Chlamydia trachomatis LGV II 434, External Run Control, Low (6 X 1 mL)

NATCT(434)-ERCL 6 X 1 mL
EUR 360

NATtrol Chlamydia trachomatis serotype D, External Run Control, Low (6 X 1 mL)

NATCT(D-UW3)-ERCL 6 X 1 mL
EUR 360

NATtrol BK Virus External Run Control, Medium (6 X 1 mL)

NATBK-ERCM 6 X 1 mL
EUR 438

NATtrol Mycoplasma genitalium External Run Control (6 x 0.25mL)

NATMGN-ERC 6 x 0.25mL
EUR 301

NATtrol Zika Virus, External Run Control, Medium (6 x 1 mL)

NATZIKV-ERCM 6 x 1 mL
EUR 425

NATtrol Epstein Barr Virus (EBV) Strain: B95-8, External Run Control-Low (6X1mL)

NATEBV-ERCL 6X1mL
EUR 349

NATtrol P. jirovecii Recombinant External Run Control (6 x 0.5mL)

NATPJI-ERC 6 x 0.5mL
EUR 365

NATtrol Flu/RSV/SARS-CoV-2 External Run Control (6 x 0.5mL)

NATFRC-ERC -
EUR 278

NATtrol Zika Virus (PRVABC59), External Run Control, Medium (6 x 1.0mL)

NATZIKV(PRV)-ERCM 6 x 1.0mL
EUR 425

NATtrol Chlamydia trachomatis LGV II 434, External Run Control, Medium (6X1mL)

NATCT(434)-ERCM 6X1mL
EUR 438

NATtrol Cytomegalovirus (CMV) Strain:AD-169 External Run Control, Medium (6X1mL)

NATCMV-ERCM 6X1mL
EUR 438

NATtrol Staphylococcus aureus (MSSA); -mecA,External Run Control, Medium (6X1mL)

NATSAU(MSSA)-ERCM 6X1mL
EUR 438

NATtrol Chlamydia trachomatis serotype D, External Run Control, Medium (6X1mL)

NATCT(D-UW3)-ERCM 6X1mL
EUR 438

NATtrol HIV Type 1 Strain: IIIB External Run Control, Medium (6 X 1 mL)

NATHIV1-ERCM 6 X 1 mL
EUR 438

NATtrol Clostridium difficile NAP1, External Run Control, Medium (6 X 1 mL)

NATCDI(NAP1)-ERCM 6 X 1 mL
EUR 557

NATtrol Mycoplasma pneumoniae M129, External Run Control, Medium (6 X 1 mL)

NATMPN(M129)-ERCM 6 X 1 mL
EUR 438

NATtrol Neisseria gonorrhoeae Z017, External Run Control, Medium (6 X 1 mL)

NATNG-ERCM 6 X 1 mL
EUR 438

NATtrol Staphylococcus aureus (MRSA) External Run Control, Medium (6 X 1 mL)

NATSAU(MRSA)-ERCM 6 X 1 mL
EUR 438

NATtrol Epstein Barr Virus (EBV) Strain:B95-8,External Run Control-Medium(6X1mL)

NATEBV-ERCM 6X1mL
EUR 425

NATtrol Escherichia coli 0157:H7;EDL933, External Run Control, Medium (6 X 1 mL)

NATECO(933)-ERCM 6 X 1 mL
EUR 438

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)

NATSARS(COV2)-ERC 6 x 0.5 mL
EUR 416

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 1.0 mL)

NATSARS(COV2)-ERC1 6 x 1.0 mL
EUR 568

Influenza B Virus IgA Control Serum

C1232A 3 mL
EUR 105

Influenza B Virus IgG Control Serum

C1232G 3 mL
EUR 105

Influenza B Virus IgM Control Serum

C1232M 3 mL
EUR 105

NATtrol Influenza A/B Positive Control (6 x 0.5mL)

NATFLUAB-6C 6 x 0.5mL
EUR 211

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

NATFLUA/B-6MC 6 X 0.5 mL
EUR 227

NATtrol Influenza A/B  Positive Control (6 X 0.5 mL)

NATFLUAB-6C-IVD 6 X 0.5 mL
EUR 231

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

MDZ046 6 X 0.5 mL
EUR 272.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

Influenza A Virus IgA Control Serum

C1231A 3 mL
EUR 105

Influenza A Virus IgG Control Serum

C1231G 3 mL
EUR 105

Influenza A Virus IgM Control Serum

C1231M 3 mL
EUR 105

NATtrol Influenza Negative Control (6 X 0.5 mL)

NATCXVA9-6MC 6 X 0.5 mL
EUR 220

NATtrol Influenza/RSV Negative Control (6 x 0.5mL)

NATCXVA9-6C 6 x 0.5mL
EUR 220

NATtrol Influenza/RSV Positive Control (6 x 0.25mL)

NATFLURSV-6L 6 x 0.25mL
EUR 272

Purified Influenza A Neuraminidase (H1N1-NA) protein control for western blot

H1N1NA11-C 100 ul
EUR 343.2

NATtrol Influenza/RSV Negative Control (6 X 0.5 mL)

NATCXVA9-6C-IVD 6 X 0.5 mL
EUR 240

NATtrol Influenza/RSV Positive Control (6 x 0.5 mL)

NATFLURSV-6C 6 x 0.5 mL
EUR 221

NATtrol Influenza/RSV Negative Control (6 X 0.5 mL)

MDZ045 6 X 0.5 mL
EUR 272.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

Influenza Rapid Test Control Pack (3 X 1.5mL)

KZMC033 3 X 1.5mL
EUR 59

Influenza A virus HA Control/blocking peptide

AB-23091-P 100ug
EUR 196.8

NATtrol Influenza A H1N1 Positive Control (6 X 0.5 mL)

NATFLUAH1N1-6MC 6 X 0.5 mL
EUR 227

Influenza A virus (H5N1) matrix protein 2 Control/blocking peptide

M2E15-P 100 ug
EUR 196.8

Influenza A virus (H1N1) matrix protein 2 Control/blocking peptide

M2E16-P 100 ug
EUR 196.8

Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide

M2E17-P 100 ug
EUR 196.8

Recombinant Purified Hemagglutinin Influenza A Virus (H11N2; A/duck/Yangzhou/906/2002) protein control for Western

H11N2-01-C 100 ul
EUR 343.2

Human anti-H. Influenzae B (Hib-PRP) IgG negative control serum

980-101-HNC 1 ml
EUR 196.8

Human anti-H. Influenzae B (Hib-PRP) IgG positive control serum

980-101-HPC 1 ml
EUR 270

Recombinant Purified Hemagglutinin Influenza A Virus H1N1 H1 (H1N1) (A/New Caledonia/20/99) protein control for Western

H1N1-01-C 100 ul
EUR 343.2

Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide

M2E11-P 100 ug
EUR 196.8

Human anti-H. Influenzae B protein D (Hib-PDG) IgG negative control serum

980-200-01N 1 ml
EUR 196.8

Human anti-H. Influenzae B protein D (Hib-PDG) IgG positive control serum

980-200-02P 1 ml
EUR 270

Recombinant Purified Hemagglutinin Influenza A Virus H5N1 H5 (H5N1) (A/chicken/India/NIV33487/2006) (17-531aa) protein control for Western

H5N11-C 100 ul
EUR 343.2

Core Panel Multi-Tumor control slides, set of 5

TS900 Set of 5
EUR 145
Description: Core Panel Multi-Tumor control slides, set of 5

Core Panel Multi-Tumor control slides, set of 25

TS900-25 Set of 25
EUR 425
Description: Core Panel Multi-Tumor control slides, set of 25

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 123.6

Breast Panel Multi-Tumor control slides, set of 5

TS901 Set of 5
EUR 145
Description: Breast Panel Multi-Tumor control slides, set of 5

Breast Panel Multi-Tumor control slides, set of 25

TS901-25 Set of 25
EUR 395
Description: Breast Panel Multi-Tumor control slides, set of 25

Control Animal Genomic DNA Panel, Set of any 5 species

G-005 5X0.025mg
EUR 720

Control Animal Genomic DNA Panel, Set of any 10 species

G-010 10x0.025mg
EUR 1193

BSA Control for Age-BSA

2221-BSA each
EUR 210

BSA Control for AGE-BSA

35R-AA007 10 mg Ask for price
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007

Recombinant H. Influenzae protein D (Non-typeable, NT-PHiD) controls for western blot

PHID11-C 100 ul
EUR 343.2

Extraction Control for Challenging Samples

TC-9109-096 each
EUR 90

Negative Control for Mouse IgG1

MC-950 NCG01 Ask for price

Negative Control for Rabbit IgG

TA353974 100 µl Ask for price

Negative Control for Rabbit IgG

PC-124 Polyclonal Ask for price

Control for ER, 4 cases (1.5mm)

ERC081 1
EUR 102
Description: IHC control array containing 4 breast cancer cases of strong, moderate, weak/nil estrogen receptor (ER) expressers in duplicates

Control for PR, 3 cases (1.5mm)

PRC061 1
EUR 102
Description: IHC control array containing 3 breast cancer cases of strong, moderate, low/negative progesterone receptor (PR) expressers in duplicates

Human Apolipoprotein B protein control for WB

APOB21-C 100 ul
EUR 343.2

Control Peptide for SNAPtideÒ #520

525 200nmoles
EUR 600

Deer IgG, semi-pure for ELISA (Control, non-immune, isotype control)

20024-2 100 ug
EUR 270

Scrambled Control for Pri Peptide

069-78 200 μg
EUR 160.92

Low control Human Serum

35-S4321H000-L4 10 ml
EUR 80
Description: Low control human Serum

Control for DOG1, 3 cases (1.5mm)

DOG1061 1
EUR 102
Description: IHC control array containing 3 GIST cases of strong, moderate, weak/nil DOG1 expressers in duplicates

Control for HER2, 4 cases (1.5mm)

HRC081 1
EUR 102
Description: IHC control array containing 4 breast cancer cases of strong, moderate, low and negative HER2 breast cancer expressers in duplicates

Control for Ckit, 6 samples (1.5mm)

CKIT061 1
EUR 102
Description: Gastrointestinal stroma tumors, 6 cores, 3 cases in duplicates showing strong, moderate and no expression of cKit molecule.

Control for Ubiquitin Affinity Beads

CUB02B-beads 10 assays
EUR 112.32

External Panel AJ Spare Parts and Accessories

710993 Box of 1 Piece(s)
EUR 229.48
Description: Description Dutch: External Panel; Description French: External Panel

Control Peptide for SNAPtide® #521

526 200nmoles
EUR 600

Control FD G6PD for Baebies FINDER

K088M-6 6 x 1 mL
EUR 194
Description: Tri-Level

Control for Immunoprecipitation IgG beads

CIG01-beads 10 assays
EUR 115.44

Flow Control Fitting for Flypad - EACH

FLY1254 EACH
EUR 114.57

Flow Control Fitting for Blowgun - EACH

FLY1252 EACH
EUR 91.07

Negative Control for Ms IgG1, Antibody

GWB-B79944 7 ml Ask for price

Negative Control for Ms IgG1, Antibody

GWB-D18CD7 1 ml Ask for price

Negative Control for Ms IgG2a, Antibody

GWB-2AA549 7 ml Ask for price

Negative Control for Ms IgG2a, Antibody

GWB-DB66F7 1 ml Ask for price

Inhibition Control for EZ‐Series Assay

TC-9110-001 each
EUR 75

SLLK, Control Peptide for TSP1 Inhibitor

HY-P0301 1mg
EUR 159.6

Negative Control for Rabbit IgG, Antibody

GWB-26C475 7 ml Ask for price

Negative Control for Rabbit IgG, Antibody

GWB-F8DD01 1 ml Ask for price

Control/Blocking peptide for Human WNT5a

WNT511-P 100 ug
EUR 196.8

PAS/Glycogen, For Digestion (Control Slides)

TCS0024-100 100 Slides
EUR 847.2

PAS/Glycogen, For Digestion (Control Slides)

TCS0024-25 25 Slides
EUR 278.4

PAS/Glycogen, For Digestion (Control Slides)

TCS0024-5 5 Slides
EUR 117.6

Rec. Human CD21 protein control for WB

CD21-C 100 ul
EUR 343.2

Thiostatin Rat protein, control for western

TSTN11-C 100 ul
EUR 343.2

Mouse IgG (-ve control for flow cytometry)

20008-1-100 100 tests
EUR 123.6

Rabbit IgG (-ve control for flow cytometry)

20009-1-100 100 tests
EUR 123.6

Human Liver Cathepsin B protein control for Western blot

CTHB11-C 100 ul
EUR 343.2

Purified, Human S100 protein control for WB

S1002-C 100 ul
EUR 343.2

Control Sections for FD NeuroSilver™ Kit

PCS101 each
EUR 69.6

Control/Blocking peptide for Human WNT-1

WNT111-P 100 ug
EUR 548.4

Control for SUM01 Immunoprecipitation IgG beads

CIG03-beads 10 assays
EUR 115.44

Negative Control Antibody for Mouse Monoclonals

V8785-100UG 100ug
EUR 424.15
Description: To serve as a true negative control for various procedures, this monoclonal IgG should be used under the identical conditions and at the same dilution as the rabbit monoclonal antibody being used for a positive reaction.

Negative Control Antibody for Mouse Monoclonals

V8785-20UG 20ug
EUR 186.15
Description: To serve as a true negative control for various procedures, this monoclonal IgG should be used under the identical conditions and at the same dilution as the rabbit monoclonal antibody being used for a positive reaction.

Negative Control Antibody for Mouse Monoclonals

V8785SAF-100UG 100ug
EUR 424.15
Description: To serve as a true negative control for various procedures, this monoclonal IgG should be used under the identical conditions and at the same dilution as the rabbit monoclonal antibody being used for a positive reaction.

Purified, Bovine S100 protein control for WB

S1001-C 100 ul
EUR 343.2

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

HY-P0301A 5mg
EUR 456

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

TP1833-10mg 10mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor(TFA)

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

TP1833-1g 1g Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor(TFA)

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

TP1833-1mg 1mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor(TFA)

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

TP1833-50mg 50mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor(TFA)

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

TP1833-5mg 5mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor(TFA)

Positive Control for Anti-Rat MEH Antibody

MEHCON 100 uL
EUR 98

GCP (green control plasmid for GFP expression)

C15 50 ul
EUR 145
Description: Protein expression

copy number positive control for custom assay

Z-any-std each
EUR 198

Human Pancreatic Amylase protein control for Western blot

PAMY13-C 100 ul
EUR 343.2

Positive Control for Anti-Rat CYP2C Antibody

P2CCON 100 uL
EUR 98

Positive Control for Anti-Rat CYP2D Antibody

P2DCON 100 uL
EUR 98

Rat IgG2a Isotype Control LOW ENDOTOXIN

12-168-C100 0.1 mg
EUR 115.5

Rat IgG2b Isotype Control LOW ENDOTOXIN

12-169-C100 0.1 mg
EUR 115.5

Normal Rabbit Control Serum (for immunohistochemistry)

NRS-IHC 500 μl
EUR 267.84

Haptoglobin Human Plasma protein control for WB

HGLB18-C 100 ul
EUR 343.2

Positive Control for Anti-Rat CYP2B1 Antibody

P2B1PTCON 100 uL
EUR 98

Positive Control for Anti-Rat CYP3A2 Antibody

P3A2PTCON 100 uL
EUR 98

Control/Blocking peptide for Mouse Vimentin (Vim)

VIM11-C 100 ug
EUR 196.8

SLLK, Control Peptide for TSP1 Inhibitor acetate

TP1833L-10mg 10mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor acetate

SLLK, Control Peptide for TSP1 Inhibitor acetate

TP1833L-1g 1g Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor acetate

SLLK, Control Peptide for TSP1 Inhibitor acetate

TP1833L-1mg 1mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor acetate

SLLK, Control Peptide for TSP1 Inhibitor acetate

TP1833L-50mg 50mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor acetate

SLLK, Control Peptide for TSP1 Inhibitor acetate

TP1833L-5mg 5mg Ask for price
Description: SLLK, Control Peptide for TSP1 Inhibitor acetate

Control for Acetylation Immunoprecipitation IgG beads

CIG02-beads 10 assays
EUR 115.44

Mouse IgG Isotype control (purified) validated for

NG903 7 ml
EUR 195
Description: Mouse IgG Isotype control (purified) validated for IHC; Ready-To-Use

Mouse IgG Isotype control (purified) validated for

NG903C 1 ml
EUR 275
Description: Mouse IgG Isotype control (purified) validated for IHC; Concentrate; Minimum 1:50 dilution

Mouse IgM Isotype control (purified) validated for

NG906 7 ml
EUR 265
Description: Mouse IgM Isotype control (purified) validated for IHC; Ready-To-Use

Mouse IgM Isotype control (purified) validated for

NG906C 1 ml
EUR 295
Description: Mouse IgM Isotype control (purified) validated for IHC; Concentrate

Positive Control for Anti-Human CYP3A Antibody

P3ACON 100 uL
EUR 98

Control/Blocking peptide for Ephrin-B2 antibody

NIVE2B-C 100 ug
EUR 196.8

Positive Control for Anti-Human CYP1B1 Antibody

PH1B1CON 100 uL
EUR 98

Positive Control for Anti-Human CYP2E1 Antibody

P2E1PTCON 100 uL
EUR 98

Positive Control for Anti-Human CYP1A2 Antibody

P1A2CON 100 uL
EUR 98

Chicken Egg Ovalbumin protein control for Western

OVA11-C 100 ul
EUR 343.2

Precision qPCR endogenous control for Saccharomycetales

Z-EC-Saccharomycetales 150 tests
EUR 198
Description: Endogenous control

Positive control tissue section for each individua

Control-slides- Set of 5
EUR 119
Description: Positive control tissue section for each individual antibody; Based on availability; INQUIRE

Positive control tissue section for each individua

Control-Slides-for-each-antibody Set of 25
EUR 355
Description: Positive control tissue section for each individual antibody; Based on availability; INQUIRE

Rat Ceruloplasmin protein control for western blot

CP17-C 100 ul
EUR 343.2

Control sections for FD NeuroApop™ Kit (frozen)

PCS102- each
EUR 87.6

Control sections for FD NeuroApop™ Kit (frozen)

PCS102-2 each
EUR 80.54
Description: Best quality products

Isotype control mAb (MT128) for mouse IgG1, PF488P

3612-71-100T 100 tests
EUR 304.5

Isotype control mAb (MT128) for mouse IgG1, PF647P

3612-72-100T 100 tests
EUR 304.5

Isotype control mAb (97B4) for mouse IgG2a, PF488P

3613-71-100T 100 tests
EUR 304.5

Isotype control mAb (97B4) for mouse IgG2a, PF647P

3613-72-100T 100 tests
EUR 304.5

Human Native Retinol binding protein (RBP) control for Western

RBP41-C 100 ul
EUR 343.2

Purified Flagellin (salmonella) protein control for WB

FLGN17-C 100 ul
EUR 343.2

Mouse Ceruloplasmin protein control for western blot

CP16-C 100 ul
EUR 343.2

Human Hemopexin purified protein control for Western

HPEX11-C 100 ul
EUR 343.2

Hemopexin Mouse, purified protein control for Western

HPEX16-C 100 ul
EUR 343.2

No RT control aliquot for nanoscript2 premix kit

Z-RT-noRT2-ctrl 5 tests
EUR 27
Description: nanoScript2

Low Level Semivolatile Control Sample - 1ML

CLPS-LC-ALCS 1ML
EUR 147.15

Lectin binding native protein (positive control for SNA lectin)

LBP16-N-1 1 ml
EUR 270

Q-VE-OPh (Negative Control for Q-VD-OPh)

GW8990-1 1
EUR 228.1

Human Apolipoprotein C-I protein control for WB

APOC11-C 100 ul
EUR 343.2

Control sections for FD NeuroApop™ Kit (paraffin)

PCS102-1 each
EUR 80.44
Description: Best quality products

Purified Human Survivin protein for WB +ve control

SURV11-C 100 ul
EUR 343.2

copy number positive control for custom rat assay

Z-ra-std each
EUR 198
Description: Control

Lectin binding native protein (negative control for all lectins)

LNP15-N-1 1 ml
EUR 270

Bovine Adenosine deaminase protein control for Western

ADA11-C 100 ul
EUR 343.2

Purified Cholera Toxin B subunit protein control for Western Blot

CTOX27-C 100 ul
EUR 343.2

Human Apolipoprotein C-II protein control for WB

APOC22-C 100 ul
EUR 343.2

Monkey (Rhesus) Serum Albumin protein control for WB

ALBMK21-C 100 ul
EUR 343.2

Monkey (Rhesus) Serum Albumin protein control for WB

ALBMK22-C 100 ul
EUR 343.2

Positive Control for Anti-Rat CHP2B1/2 Antibody

P2B12PTCON 100 uL
EUR 98

Conclusions: The findings WES has led us to identify new variants were reported as well as for the first time in India CMD and CM patients. This allows us to achieve an accurate genetic diagnosis that are otherwise difficult using conventional diagnostic tools. Transferring WES findings for clinical practice will help the clinical care of patients affected guided and informed genetic counseling.

Related Posts

Leave a Reply

Your email address will not be published.